Barberry (European Barberry) |
|
Basic Information
Biological name (genus and species):
Berberis vulgaris
Parts used for medicinal purposes:
Berries/fruits
Rootbark
Chemicals this herb contains:
Berbamine
Berberine
Berberrubine
Columbamine
Hydrastine
Jatrorrhizine
Oxycanthine
Palmatine
KNOWN EFFECTS
Dilates blood vessels.
Decreases heart rate.
Depresses breathing.
Stimulates intestinal movement.
Reduces bronchial constriction.
Kills bacteria on skin.
Miscellaneous information:
Fruit is made into jelly.
Roots are used to dye wool.
Benefits are mainly based in folklore.
UNPROVED SPECULATED BENEFITS
Treats diarrhea.
Treats dyspepsia.
Treats skin infections.
WARNINGS AND PRECAUTIONS
Don't take if you:
Are pregnant, think you may be pregnant or plan pregnancy in
the near future.
Take this herb for any medical problem that doesn't improve in
2 weeks. There may be safer, more-effective treatments.
Consult your doctor if you:
Take any medicinal drugs or herbs including aspirin, laxatives,
cold and cough remedies, antacids, vitamins, minerals, amino
acids, supplements, other prescription or non-prescription
drugs.
Pregnancy:
Dangers outweigh any possible benefits. Don't use.
Breast-feeding:
Dangers outweigh any possible benefits. Don't use.
Infants and children:
Treating infants and children under 2 with any herbal
preparation is hazardous.
Others:
None expected if you are beyond childhood and under 45,
basically healthy and take for only a short time.
Storage:
Keep cool and dry, but don't freeze. Store safely away from
children.
Safe dosage:
At present no "safe" dosage has been established.
TOXICITY
Rated slightly dangerous, particularly in children, persons
over 55 and those who take larger than appropriate quantities for
extended periods of time.
ADVERSE REACTIONS, SIDE EFFECTS OR OVERDOSE SYMPTOMS
None expected
|
|
|
|
Dserun mollit anim id est laborum. Lorem ipsum and sunt in culpa qui officias deserunt mollit. Excepteur plus sint occaecat the best cupidatat nonr proident, sunt in culpa qui officia deserunt mollit anim id est laborum. September 24, 2004
